Viewing Study NCT06667167


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-25 @ 11:08 PM
Study NCT ID: NCT06667167
Status: RECRUITING
Last Update Posted: 2025-01-17
First Post: 2024-10-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
Sponsor: Nir Peled
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module